Abstract
In this study, we analyze the amino acid pairs in human protein C precursor to determine which amino acid pairs are more susceptible to 71 variants from missense mutant human protein C precursor. The results show 85.92% of 71 variants occur at randomly unpredictable amino acid pairs accounting for 61.96% of amino acid pairs in protein C.
Keywords: protein c, probability, randomness, thrombophilia, variant, cycloamylose
Protein & Peptide Letters
Title: Amino Acid Pairs Susceptible to Variants in Human Protein C Precursor
Volume: 12 Issue: 5
Author(s): Guang Wu and Shaomin Yan
Affiliation:
Keywords: protein c, probability, randomness, thrombophilia, variant, cycloamylose
Abstract: In this study, we analyze the amino acid pairs in human protein C precursor to determine which amino acid pairs are more susceptible to 71 variants from missense mutant human protein C precursor. The results show 85.92% of 71 variants occur at randomly unpredictable amino acid pairs accounting for 61.96% of amino acid pairs in protein C.
Export Options
About this article
Cite this article as:
Wu Guang and Yan Shaomin, Amino Acid Pairs Susceptible to Variants in Human Protein C Precursor, Protein & Peptide Letters 2005; 12 (5) . https://dx.doi.org/10.2174/0929866054395248
DOI https://dx.doi.org/10.2174/0929866054395248 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Angiogenesis Inhibitors: Current & Future Directions
Current Pharmaceutical Design Perioperative Safety of Warfarin Therapy and Reversal
Current Drug Safety Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory
Current Cardiology Reviews Optic Nerve and Cerebral Edema in the Course of Diabetic Ketoacidosis
Current Neuropharmacology New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews Balancing the Risks of Thrombosis and Bleeding Following Transcatheter Aortic Valve Implantation: Current State-of-Evidence
Current Pharmaceutical Design Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum
Current Pharmaceutical Design The Structure and Pharmacological Functions of Coumarins and Their Derivatives
Current Medicinal Chemistry Acute Antithrombotic Treatment of Ischemic Stroke
Current Vascular Pharmacology Catastrophic Antiphospholipid Syndrome - 20 Years Later
Current Rheumatology Reviews Clinical Characteristics and Treatment of Cardiomyopathies in Children
Current Cardiology Reviews Editorial [Hot topic: An Update on Venous Thromboembolism in Trauma, Orthopaedic and Reconstructive Surgery (Guest Editors: Peter V. Giannoudis and Panayotis N. Soucacos)]
Current Vascular Pharmacology Novel Risk Factors Related to Stable Angina
Current Pharmaceutical Design Therapeutic Perspectives in the Antiphospholipid Syndrome
Current Rheumatology Reviews The Role of Hypoxia and Platelets in Air Travel-Related Venous Thromboembolism
Current Pharmaceutical Design Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Pathophysiology and Pharmacologic Treatment of Venous Thromboembolism
Current Drug Targets